title: Response to "Association between statin use and ischemic stroke or major hemorrhage in patients taking dabigatran for atrial fibrillation".
authors.affiliation: Department of Family and Community Medicine; Li Ka Shing Knowledge Institute, St. Michael's Hospital; University of Toronto; Institute for Clinical Evaluative Sciences, Toronto, Ont.
authors.forename: Tony
authors.initials: T
authors.lastname: Antoniou
authors.affiliation: Li Ka Shing Knowledge Institute, St. Michael's Hospital; University of Toronto; Institute for Clinical Evaluative Sciences; Applied Health Research Centre, St. Michael's Hospital, Toronto, Ont.; King Saud University, Riyadh, Saudi Arabia.
authors.forename: Muhammad
authors.initials: M
authors.lastname: Mamdani
authors.affiliation: University of Toronto; Institute for Clinical Evaluative Sciences, Toronto, Ont.
authors.forename: David
authors.initials: D
authors.lastname: Juurlink
mesh_terms: D000925:Anticoagulants; D001281:Atrial Fibrillation; D001562:Benzimidazoles; D000069604:Dabigatran; D006470:Hemorrhage; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D020521:Stroke; D014859:Warfarin
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D014859:Warfarin; D000069604:Dabigatran